Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-037598
Filing Date
2020-11-17
Accepted
2020-11-17 11:59:26
Documents
87
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0920_americanbrivision.htm 10-Q 969255
2 CERTIFICATION f10q0920ex31-1_american.htm EX-31.1 18606
3 CERTIFICATION f10q0920ex31-2_american.htm EX-31.2 16834
4 CERTIFICATION f10q0920ex32-1_american.htm EX-32.1 6499
5 CERTIFICATION f10q0920ex32-2_american.htm EX-32.2 6166
6 GRAPHIC image_001.jpg GRAPHIC 39382
  Complete submission text file 0001213900-20-037598.txt   6428905

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE abvcd-20200930.xml EX-101.INS 1129937
8 XBRL SCHEMA FILE abvcd-20200930.xsd EX-101.SCH 77913
9 XBRL CALCULATION FILE abvcd-20200930_cal.xml EX-101.CAL 72963
10 XBRL DEFINITION FILE abvcd-20200930_def.xml EX-101.DEF 259979
11 XBRL LABEL FILE abvcd-20200930_lab.xml EX-101.LAB 431557
12 XBRL PRESENTATION FILE abvcd-20200930_pre.xml EX-101.PRE 386862
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-91436 | Film No.: 201319973
SIC: 2834 Pharmaceutical Preparations